Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Johnson & Johnson gets court reversal of verdict over talc cancer risks

Published 10/17/2017, 06:31 PM
Updated 10/17/2017, 06:31 PM
© Reuters.  Johnson & Johnson gets court reversal of verdict over talc cancer risks
  • Johnson & Johnson (NYSE:JNJ) today won a reversal of a $72M verdict that had favored the family of a woman whose death from ovarian cancer they claimed was caused by her use of the company’s talc-based products.
  • A Missouri Court of Appeals said that given a recent U.S. Supreme Court decision that limited where injury lawsuits could be filed, the case over the Alabama resident’s death should not have been tried in St. Louis.
  • JNJ faces lawsuits by 4,800 plaintiffs nationally asserting similar claims over its talc-based products, with many in Missouri, where the February 2016 verdict for the family was the first of four jury awards totaling $307M, and in California, where in August a jury awarded a woman $417M.
  • Now read: Understanding Johnson & Johnson's Spectacular Q3 Performance

Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.